are they banning compounded semaglutide 📢 FDA has determined the shortage of injection products, a glucagon-like peptide 1 (GLP-1) medication, is resolved. Patients and prescribers may still see intermittent and limited localized supply disruptions as the FDA moves to remove GLP-1

NICE PH53

Patients with a personal or family history of medullary thyroid cancer or multiple endocrine neoplasia syndrome type 2 should not use this medication

Once submitted, a licensed medical provider reviews your information

For best results, supplements should be used as part of a comprehensive health strategy including nutrition, lifestyle, and medical evaluation when appropriate

Certificate Program in Nutrition Strategies Build a strong foundation in whole-food nutrition, metabolic health, and evidence-based dietary strategies to achieve lasting health and wellness transformations However, despite its potent effects, endogenous GLP-1 has a very short half-life of just 1-2 minutes due to rapid degradation by the dipeptidyl peptidase-4 (DPP-4) enzyme

Balancing Benefits with Safety Like all powerful therapies, retatrutide comes with considerations that patients and clinicians must weigh carefully